Demidchik Yuri E, Demidchik Eugene P, Reiners Christoph, Biko Johannes, Mine Mariko, Saenko Vladimir A, Yamashita Shunichi
Department for Oncology, Belarusian State Medical University, Minsk, Belarus.
Ann Surg. 2006 Apr;243(4):525-32. doi: 10.1097/01.sla.0000205977.74806.0b.
A retrospective study was designed to evaluate the results of surgical treatment and follow-up data in thyroid cancer patients less than 15 years old at the time of surgery.
Pediatric thyroid carcinomas have a high rate of lymph nodal and distant metastases. Risk factors for recurrences and postoperative morbidity have not been assessed yet in a representative series.
The group included 740 pediatric patients with thyroid cancer. Total thyroidectomy was performed in 426 (57.6%), lobectomy in 248 (33.5%), subtotal thyroidectomy in 58 (7.8%) cases, and 8 patients (1.1%) underwent partial lobectomy.
The mean follow-up period was 115.8 months (range, 1.5-236.4 months). Recurrence was diagnosed in 204 cases (27.6%), including 73 local relapses (9.9%), 90 distant metastases (12.2%), and a combination of local and distant recurrences in 41 (5.5%) patients. Multivariate statistical assessment revealed the following independent parameters significantly associated with the risk of recurrent nodal disease: a young age at diagnosis, multifocal carcinomas, N1 status, and lack of neck lymph node dissection. For lung metastases, the significant risk factors were female gender, young age at diagnosis, and presence of symptoms. The observed 5- and 10-year survival for the entire group was 99.5% and 98.8%, respectively. Postoperative hypoparathyroidism was significantly associated with multifocal tumors, central compartment removal, and ipsilateral dissection.
Total thyroidectomy followed by radioiodine therapy is an optimal treatment strategy that makes it possible to achieve a cure in a vast majority of pediatric patients with differentiated thyroid carcinomas. Risk of recurrence is strongly associated with tumor stage, extent of surgery, the young patient's age, and presence of symptoms at diagnosis.
开展一项回顾性研究,以评估手术时年龄小于15岁的甲状腺癌患者的手术治疗结果及随访数据。
儿童甲状腺癌有较高的淋巴结转移和远处转移率。在一个具有代表性的系列研究中,尚未对复发风险因素和术后发病率进行评估。
该组包括740例儿童甲状腺癌患者。426例(57.6%)行甲状腺全切除术,248例(33.5%)行甲状腺叶切除术,58例(7.8%)行甲状腺次全切除术,8例(1.1%)行甲状腺部分叶切除术。
平均随访期为115.8个月(范围1.5 - 236.4个月)。204例(27.6%)诊断为复发,其中73例为局部复发(9.9%),90例为远处转移(12.2%),41例(5.5%)患者为局部和远处复发并存。多变量统计评估显示,以下独立参数与复发淋巴结疾病风险显著相关:诊断时年龄小、多灶性癌、N1状态以及未行颈部淋巴结清扫。对于肺转移,显著风险因素为女性、诊断时年龄小以及有症状。整个组观察到的5年和10年生存率分别为99.5%和98.8%。术后甲状旁腺功能减退与多灶性肿瘤、中央区切除和同侧清扫显著相关。
甲状腺全切除术后行放射性碘治疗是一种最佳治疗策略,可使绝大多数分化型甲状腺癌儿童患者实现治愈。复发风险与肿瘤分期、手术范围、患者年龄小以及诊断时有无症状密切相关。